22/08/2025
Insulin resistance is a silent condition that increases the risk of Type 2 diabetes, prediabetes, and cardiovascular disease. Detecting it early can transform patient care and outcomes.
Why choose ichroma™/AFIAS Insulin?
Accurate early detection of insulin resistance before glucose levels rise.
Identifies hyperinsulinemia, a key marker of insulin resistance.
Enables HOMA-IR calculation: a mathematical model for assessing insulin resistance.
Supports timely lifestyle and dietary interventions, reducing progression to diabetes.
Helps monitor patients with metabolic syndrome and stratify cardiovascular risk.
Equip your clinic with ichroma™/AFIAS Insulin testing and empower your patients with the knowledge they need to take control of their health.